European Union: Food and Drugs Law

This month, at the Unified Patent Court (UPC), the Düsseldorf Local Division’s dismissal of Align Technology’s provisional measures application against Angelalign reinforces the applicant’s evidential...

June 2026 – In case Kfv.VI.37.810/2025/27, the Hungarian Supreme Court (the “Supreme Court”) reviewed an administrative dispute concerning the marketing authorisation of a generic medicinal product.

Recent U.S. case law is reshaping the risks around skinny labelling strategies for generics. What was once seen as a safe regulatory pathway now raises new concerns about infringement

João Taborda da Gama continues to shape international discourse on psychedelic regulation, speaking at major European forums on the legal, ethical, and philosophical tensions surrounding controlled substances. His recent presentations in Ukraine and Portugal examine who holds authority over consciousness-altering therapies, whether existing frameworks reflect coherent principles or accumulated habit, and what risks and possibilities fall outside medicalization's reach.

The Decision of the Ministries of Health and Digital Governance, published on 3 March 2026 (the Decision), establishes the Digital Registry for the Monitoring of Tobacco, Alcohol and Other Non-Tobacco Products (the Registry), which operates through the gov.gr digital platform.

In our fifth alert in this EU Pharma Package Series, we provided an analysis of the background and ongoing legal debates regarding the concept of the global marketing authorization (GMA).

Drug trafficking is considered "international" when the unlawful activity contains an element of transnationality, meaning it involves more than one State from a material, personal, or legal standpoint.

In 2023, the CNIL established a dedicated service for the economic analysis of issues related to personal data, with the aim of strengthening its expertise and informing its decisions through impact assessments...

Der Bundesgerichtshof (BGH) hat in einer Grundsatzentscheidung (I ZR 74/24 – Arzneimittel-Check) entschieden, dass nationale Gerichte auch in Streitigkeiten zwischen privaten...